Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

BACKGROUND: Obesity has a large prevalence among HIV-infected patients. Increased adipose tissue mass affects the pharmacokinetics of numerous drugs, but only a few data are available for antiretroviral drugs. OBJECTIVE: In this study, we aimed to explore the pharmacokinetics of antiretroviral drugs...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Antimicrob Chemother
Main Authors: Madelain, Vincent, Le, Minh, Champenois, Karen, Charpentier, Charlotte, Landman, Roland, Joly, Veronique, Yeni, Patrick, Descamps, Diane, Yazdanpanah, Yazdan, Peytavin, Gilles
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5517629/
https://ncbi.nlm.nih.gov/pubmed/28065890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw527
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares